X4 Pharmaceuticals, Inc (XFOR) › Shareholders' EquityX4 Pharmaceuticals, Inc (XFOR) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2015: -$34.32M2016: -$23.05M2017: -$44.55M2018: -$77.09M2019: $129.22M2020: $72.80M2021: $64.41M2022: $74.05M2023: $51.10M2024: $22.15M2025: $186.29M$186.29M2015Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$186.29M+741.1%2024$22.15M-56.7%2023$51.10M-31.0%2022$74.05M+15.0%2021$64.41M-11.5%2020$72.80M-43.7%2019$129.22M+267.6%2018-$77.09M-73.1%2017-$44.55M-93.2%2016-$23.05M+32.8%2015-$34.32M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share